Clinical application of nebulized opioids for treatment of dyspnoea in patients with malignant disease
- PMID: 7518312
- DOI: 10.1007/BF00417478
Clinical application of nebulized opioids for treatment of dyspnoea in patients with malignant disease
Abstract
This article describes our experience in the clinical use of nebulized opioids for the management of dyspnoea in patients with terminal cancer by reviewing three specific patient case studies in which this treatment was found to be both safe and effective in controlling breathlessness. The patients were treated with morphine, hydromorphone or anileridine in various doses according to their prior use of opioids. Additional formal studies are being initiated at this Centre.
Similar articles
-
Nebulized opioids in the treatment of dyspnea.J Palliat Care. 1997 Autumn;13(3):48-52. J Palliat Care. 1997. PMID: 9354041 No abstract available.
-
Nebulized hydromorphone for dyspnea in hospice care of advanced cancer.Am J Hosp Palliat Care. 2000 Nov-Dec;17(6):389-91. doi: 10.1177/104990910001700609. Am J Hosp Palliat Care. 2000. PMID: 11886040 Review.
-
Nebulized opioids for the palliation of dyspnea in terminally ill patients.Am J Health Syst Pharm. 2017 Jul 15;74(14):1053-1061. doi: 10.2146/ajhp150893. Am J Health Syst Pharm. 2017. PMID: 28687551 Review.
-
Nebulized morphine in the palliation of dyspnoea.Palliat Med. 1997 Jul;11(4):267-75. doi: 10.1177/026921639701100402. Palliat Med. 1997. PMID: 9373577 Clinical Trial.
-
Nebulized morphine for relief of dyspnea due to chronic lung disease.Ann Pharmacother. 2005 Jun;39(6):1088-92. doi: 10.1345/aph.1E328. Epub 2005 Apr 19. Ann Pharmacother. 2005. PMID: 15840735 Review.
Cited by
-
Effect of hydromorphone on ventilation in palliative care patients with dyspnea.Support Care Cancer. 2008 Jan;16(1):93-9. doi: 10.1007/s00520-007-0310-3. Epub 2007 Oct 11. Support Care Cancer. 2008. PMID: 17929063 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical